Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer

Pathology and Oncology Research

Volumn 20, Issue 3, 2014, Pages 549-556

  Zhou, Yiqun ^a   Wan, Chunhua ^a   Liu, Yifei ^a   Lv, Liting ^a   Chen, Buyou ^a   Ni, Runzhou ^a   Huang, Yuexia ^a   Li, Yangcheng ^a   Zheng, Xiaodong ^a   Yang, Dunpeng ^a   Mao, Guoxin ^a   Xue, Qun ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Prognosis; RING1

Indexed keywords

POLYCOMB GROUP PROTEIN; PROTEIN RING1; UNCLASSIFIED DRUG; BMI1 PROTEIN; RING1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MALE; ONCOGENE; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RING FINGER PROTEIN 1 GENE; RNA INTERFERENCE; SURVIVAL RATE; TISSUE SECTION; UPREGULATION; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CELL CYCLE; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; LARGE CELL CARCINOMA; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYCOMB REPRESSIVE COMPLEX 1; PROGNOSIS; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84904112983     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9727-9     Document Type: Article

References (34)

1. Buchenau P, Hodgson J, Strutt H, Arndt-Jovin DJ (1998) The distribution of poly-comb-group proteins during cell division and development in Drosophila embryos: impact on models for silencing. J Cell Biol 141(2):469-481 (Pubitemid 28237094)
2. Caldas C, Aparicio S (1999) Cellmemory and cancer-the story of the trithorax and Poly-comb group genes. Cancer Metastasis Rev 18(2):313-329 (Pubitemid 30043865)
3. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P et al (2002) Role of histone H3 lysine 27 methylation in Poly-comb-group silencing. Science 298(5595):1039-1043 (Pubitemid 35247314)
4. Cao W, Ribeiro Rde O, Liu D, Saintigny P, Xia R, Xue Y et al (2012) EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. PLoS One 7(12):e52984
5. Cooper CS, Foster CS (2009) Concepts of epigenetics in prostate cancer development. Br J Cancer 100(2):240-245
6. Czermin B, Melfi R, McCabe D, Seitz V, Imhof A, Pirrotta V (2002) Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Poly-comb sites. Cell 111(2):185-196 (Pubitemid 35292439)
7. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M et al (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62(16):4736-4745
8. Ferraiuolo MA, Rousseau M, Miyamoto C, Shenker S, Wang XQ, Nadler M et al (2010) The three-dimensional architecture of Hox cluster silencing. Nucleic Acids Res 38(21):7472-7484
9. Fussbroich B, Wagener N, Macher-Goeppinger S, Benner A, Falth M, Sultmann H et al (2011) EZH2 depletion blocks the proliferation of colon cancer cells. PLoS One 6(7):e21651
10. Goebl MG (1991) The bmi-1 and mel-18 gene products define a new family of DNA-binding proteins involved in cell proliferation and tumorigenesis. Cell 66(4):623
11. Hinz S, Kempkensteffen C, Christoph F, Krause H, Schrader M, Schostak M et al (2008) Expression parameters of the poly-comb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Tumour Biol 29(5):323-329
12. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13(20):2678-2690 (Pubitemid 29508555)
13. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300
14. Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y et al (2009) Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Exp Mol Pathol 87(3):167-172
15. Kerr KM (2013) Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification. J Clin Pathol 66(10):832-8
16. Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, Zemp F et al (2007) Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant micro-RNA expression. Cell Cycle 6(16):2010-2018 (Pubitemid 47327889)
17. Li H, Bitler BG, Vathipadiekal V, Maradeo ME, Slifker M, Creasy CL et al (2012) ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches. Cancer Prev Res (Phila) 5(3):484-491
18. Li Z, Qu L, Dong Q, Huang B, Li H, Tang Z et al (2012) Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One 7(5):e36903
19. Lu, C., Liu, G., Cui, X., Zhang, J., Wei, L., Wang, Y., et al. (2013). Expression of SGTA Correlates with Prognosis and Tumor Cell Proliferation in Human Hepatocellular Carcinoma. Pathol Oncol Res
20. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442
21. Qin H, Wang J, Liang Y, Taniguchi Y, Tanigaki K, Han H (2004) RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucleic Acids Res 32(4):1492-1501 (Pubitemid 38854749)
22. Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H et al (2003) Poorly differentiated breast carcinoma is associated with increased expression of the human poly-comb group EZH2 gene. Neoplasia 5(6):481-488 (Pubitemid 38045085)
23. Raaphorst FM, Vermeer M, Fieret E, Blokzijl T, Dukers D, Sewalt RG et al (2004) Site-specific expression of poly-comb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas. Am J Pathol 164(2):533-542 (Pubitemid 38364669)
24. Satijn DP, Otte AP (1999) RING1 interacts with multiple Poly-comb-group proteins and displays tumorigenic activity. Mol Cell Biol 19(1):57-68 (Pubitemid 29018409)
25. Satijn DP, Gunster MJ, van der Vlag J, Hamer KM, Schul W, Alkema MJ et al (1997) RING1 is associated with the poly-comb group protein complex and acts as a transcriptional repressor. Mol Cell Biol 17(7):4105-4113 (Pubitemid 27281887)
26. Satijn DP, Olson DJ, van der Vlag J, Hamer KM, Lambrechts C, Masselink H et al (1997) Interference with the expression of a novel human poly-comb protein, hPc2, results in cellular transformation and apoptosis. Mol Cell Biol 17(10):6076-6086 (Pubitemid 27411116)
27. Shin YJ, Kim JH (2012) The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 7(1):e30393
28. Travis WD, Brambilla E, Muller-Hermelink HK et al (2004) World Health Organisation Classification of Tumors. Pathology and Genetics of tumors of the lung. Thymus and Heart, p 1
29. van Leenders GJ, Dukers D, Hessels D, van den Kieboom SW, Hulsbergen CA, Witjes JA et al (2007) Poly-comb-group oncogenes EZH2, BMI1, and RING1 are over-expressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 52(2):455-463 (Pubitemid 46963432)
30. Wang Y, Fei M, Cheng C, Zhang D, Lu J, He S et al (2008) Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Cancer Biol Ther 7(3):460-467 (Pubitemid 351847068)
31. Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan Q et al (2012) Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J Cell Biochem 113(8):2729-2737
32. Watanabe H, Soejima K, Yasuda H, Kawada I, Nakachi I, Yoda S et al (2008) Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 8:15
33. Xu X, Yamamoto H, Sakon M, Yasui M, Ngan CY, Fukunaga H et al (2003) Over-expression of CDC25A phosphatase is associated with hyper-growth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res 9(5):1764-1772 (Pubitemid 36554602)
34. Zhang Y, Peng C, Wu G, Wang Y, Liu R, Yang S et al (2011) Expression of NLK and its potential effect in ovarian cancer chemotherapy. Int J Gynecol Cancer 21(8):1380-1387